A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients	17p- Syndrome, Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, chromosome 17p deletion, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Active, not recruiting	Phase 2	2026-09-09		NCT04124497

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fondazione EMN Italy Onlus	4

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
A.O. Santa Maria	Terni	Italy	2
A.O. Spedali Civili di Brescia	Brescia	Italy	6
AOU Città della Salute e della Scienza di Torino - Presidio Molinette	Torino	Italy	1
AOU Ospedali Riuniti Umberto I	Ancona	Italy	3
AOU Policlinico Vittorio Emanuele	Catania	Italy	2
Dipart. Di Medicina Interna e Scienze Biomediche	Parma	Italy	1
Istituto Clinico Humanitas	Rozzano	Italy	16
Ospedale Maggiore	Novara	Italy	3
Ospedale Niguarda Cà Grande	Milan	Italy	2
Ospedale Oncologico Regionale	Rionero in Vulture	Italy	2
Ospedali Riuniti	Bergamo	Italy	2
Policlinico S. Orsola	Bologna	Italy	3
Policlinico Umberto I - Università La Sapienza	Roma	Italy	3
Policlinico Universitario di Udine	Udine	Italy	3
Policlinico-Università degli Studi	Bari	Italy	1